Surrey Heartlands

Joint Formulary & PAD

Triamcinolone acetonide - Opacification of vitreous

You are here : Home > Formulary Search > Triamcinolone acetonide - Opacification of vitreous

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Intracameral injection
  • Intravitreal injection
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Restrictions / Comments :
Important
RSCH: also used for subtenon / orbital floor injections

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Triamcinolone acetonide
Indication :
Opacification of vitreous
Group Name :
Keywords :
Brand Names Include :
Intracinol
Important Information :
40mg/mL Preservative Free Ophthalmic Suspension (Medical Device)
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Triamcinolone acetonide is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Opacification of vitreous.

  • No records returned.

Committee Recommendations (1)

02 Oct 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.